MILLENNIUM MANAGEMENT LLC - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 48 filers reported holding AUTOLUS THERAPEUTICS PLC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q2 2024$2,829,348
+16.5%
813,031
+113.7%
0.00%0.0%
Q1 2024$2,427,769
+520.8%
380,528
+526.6%
0.00%
Q4 2023$391,101
+58889.6%
60,730
-83.1%
0.00%
Q1 2023$663
+177.4%
360,145
+186.6%
0.00%
Q4 2022$239
-99.9%
125,650
+59.0%
0.00%
Q3 2022$169,000
-74.9%
79,010
-66.8%
0.00%
Q2 2022$673,000
-3.7%
237,659
+41.8%
0.00%
Q1 2022$699,000
-56.6%
167,566
-46.0%
0.00%
-100.0%
Q4 2021$1,611,000
-44.5%
310,324
-30.0%
0.00%
-50.0%
Q3 2021$2,904,000
-39.7%
443,431
-38.9%
0.00%
-33.3%
Q2 2021$4,815,000
+267.8%
725,172
+217.3%
0.00%
+200.0%
Q1 2021$1,309,000
+374.3%
228,509
+640.2%
0.00%
Q4 2020$276,000
-84.0%
30,873
-79.2%
0.00%
-100.0%
Q3 2020$1,726,000
-85.2%
148,320
-79.6%
0.00%
-87.5%
Q2 2020$11,651,000
+148.4%
726,841
-7.2%
0.02%
+45.5%
Q1 2020$4,691,000
-47.5%
783,164
+15.8%
0.01%0.0%
Q4 2019$8,930,000
-48.5%
676,481
-51.5%
0.01%
-59.3%
Q3 2019$17,340,000
+40.3%
1,396,142
+81.8%
0.03%
+42.1%
Q2 2019$12,362,000
-12.8%
767,836
+70.5%
0.02%
-9.5%
Q1 2019$14,173,000
+3590.9%
450,362
+3749.2%
0.02%
+2000.0%
Q4 2018$384,000
-64.6%
11,700
-67.5%
0.00%0.0%
Q3 2018$1,084,000
-72.3%
35,958
-75.4%
0.00%
-80.0%
Q2 2018$3,910,000145,9450.01%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q2 2018
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 7,346,829$15,723,00027.32%
TFG Asset Management GP Ltd 3,039,381$6,504,0000.78%
Nantahala Capital Management 5,215,788$11,162,0000.72%
Frazier Life Sciences Management, L.P. 3,746,857$8,018,0000.62%
HARBOR CAPITAL ADVISORS, INC. 148,454$318,0000.29%
DAFNA Capital Management LLC 496,150$1,062,0000.29%
Blackstone Inc. 17,985,611$38,4890.14%
Ikarian Capital, LLC 260,087$556,0000.11%
MYDA Advisors LLC 100,000$214,0000.10%
Privium Fund Management B.V. 113,528$253,0000.09%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders